Isoform-selective induction of human p110δ PI3K expression by TNFα: Identification of a new and inducible PIK3CD promoter

Biochemical Journal

Volumn 443, Issue 3, 2012, Pages 857-867

  Whitehead, Maria A ^a   Bombardieri, Michele ^a   Pitzalis, Costantino ^a   Vanhaesebroeck, Bart ^a,b,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c Activiomics   (United Kingdom)

Author keywords

Bioinformatics; Cytokine; Inflammation; PIK3CD; Promoter; Tumour necrosis factor (TNF )

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P110; PROTEIN P110 DELTA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SOLID TUMOR; SYNOVIOCYTE;

CELLS, CULTURED; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84860213415     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20112214     Document Type: Article

References (37)

1. Engelman, J. A. (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat. Rev. Cancer 9, 550-562
2. Holmes, D. (2011) PI3K pathway inhibitors approach junction. Nat. Rev. Drug Discovery 10, 563-564
3. Jarvis, L. M. (2011) PI3K at the clinical crossroads. Chem. Eng. News 89, 15-19
4. Vanhaesebroeck, B., Welham, M. J., Kotani, K., Stein, R., Warne, P. H., Zvelebil, M. J., Higashi, K., Volinia, S., Downward, J. and Waterfield, M. D. (1997) p110δ, a novel phosphoinositide 3-kinase in leukocytes. Proc. Natl. Acad. Sci. U.S.A. 94, 4330-4335 (Pubitemid 27194241)
5. Chantry, D., Vojtek, A., Kashishian, A., Holtzman, D. A., Wood, C., Gray, P. W., Cooper, J. A. and Hoekstra, M. F. (1997) p110δ, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes. J. Biol. Chem. 272, 19236-19241 (Pubitemid 27337713)
6. Furman, R. R., Byrd, J. C., Brown, J. R., Coutre, S. E., Benson, Jr, D. M., Wagner-Johnston, N. D., Flinn, I. W., Kahl, B. S., Spurgeon, S. E., Lannutti, B. et al. (2010) CAL-101, an isoform-selective inhibitor of phosphatidylinositol 3-kinase p110δ, demonstrates clinical activity and pharmacodynamic effects in patients with relapsed or refractory chronic lymphocytic leukemia. http://ash.confex.com/ash/2010/webprogram/ Paper32870.html (Abstract)
7. Fruman, D. A. and Rommel, C. (2011) PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic. Cancer Discovery 1, 562-572
8. Kok, K., Nock, G. E., Verrall, E. A., Mitchell, M. P., Hommes, D. W., Peppelenbosch, M. P. and Vanhaesebroeck, B. (2009) Regulation of p110δ PI 3-kinase gene expression. PLoS ONE 4, e5145
9. Shimizu-Hirota, R., Xiong, W., Baxter, B. T., Kunkel, S. L., Maillard, I., Chen, X. W., Sabeh, F., Liu, R., Li, X. Y. and Weiss, S. J. (2012) MT1-MMP regulates the PI3Kδ•Mi-2/NuRD-dependent control of macrophage immune function. Genes Dev. 26, 395-413
10. Sawyer, C., Sturge, J., Bennett, D. C., O'Hare, M. J., Allen, W. E., Bain, J., Jones, G. E. and Vanhaesebroeck, B. (2003) Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110δ. Cancer Res. 63, 1667-1675 (Pubitemid 36373660)
11. Eickholt, B. J., Ahmed, A. I., Davies, M., Papakonstanti, E. A., Pearce, W., Starkey, M. L., Bilancio, A., Need, A. C., Smith, A. J., Hall, S. M. et al. (2007) Control of axonal growth and regeneration of sensory neurons by the p110δ PI 3-kinase. PLoS ONE 2, e869
12. Puri, K. D., Doggett, T. A., Douangpanya, J., Hou, Y., Tino, W. T., Wilson, T., Graf, T., Clayton, E., Turner, M., Hayflick, J. S. and Diacovo, T. G. (2004) Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue. Blood 103, 3448-3456 (Pubitemid 38525677)
13. Conte, E., Fruciano, M., Fagone, E., Gili, E., Caraci, F., Iemmolo, M., Crimi, N. and Vancheri, C. (2011) Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms. PLoS ONE 6, e24663
14. Northcott, C. A., Poy, M. N., Najjar, S. M. and Watts, S. W. (2002) Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats. Circ. Res. 91, 360-369 (Pubitemid 34977003)
15. Tsybouleva, N., Zhang, L., Chen, S., Patel, R., Lutucuta, S., Nemoto, S., DeFreitas, G., Entman, M., Carabello, B. A., Roberts, R. and Marian, A. J. (2004) Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation 109, 1284-1291 (Pubitemid 38372788)
16. Pinho, J. F., Medeiros, M. A., Capettini, L. S., Rezende, B. A., Campos, P. P., Andrade, S. P., Cortes, S. F., Cruz, J. S. and Lemos, V. S. (2010) Phosphatidylinositol 3-kinase-delta up-regulates L-type Ca2+ currents and increases vascular contractility in a mouse model of Type 1 diabetes. Br. J. Pharmacol. 161, 1458-1471
17. Bombardieri, M., Kam, N. W., Brentano, F., Choi, K., Filer, A., Kyburz, D., McInnes, I. B., Gay, S., Buckley, C. and Pitzalis, C. (2011) A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Ann. Rheum. Dis. 70, 1857-1865
18. Hirth, A., Skapenko, A., Kinne, R. W., Emmrich, F., Schulze-Koops, H. and Sack, U. (2002) Cytokine mRNA and protein expression in primary-culture and repeated-passage synovial fibroblasts from patients with rheumatoid arthritis. Arthritis Res. 4, 117-125 (Pubitemid 34257345)
19. Livak, K. J. and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔCT ] method. Methods 25, 402-408 (Pubitemid 34164012)
20. Ogilvy, S., Elefanty, A. G., Visvader, J., Bath, M. L., Harris, A. W. and Adams, J. M. (1998) Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment. Blood 91, 419-430 (Pubitemid 28053363)
21. Birney, E., Stamatoyannopoulos, J. A., Dutta, A., Guigo, R., Gingeras, T. R., Margulies, E. H., Weng, Z., Snyder, M., Dermitzakis, E. T., Thurman, R. E. et al. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816
22. Okkenhaug, K. and Vanhaesebroeck, B. (2003) PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3, 317-330 (Pubitemid 37328684)
23. Edgell, C. J., McDonald, C. C. and Graham, J. B. (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U.S.A. 80, 3734-3737 (Pubitemid 13063134)
24. Unger, R. E., Krump-Konvalinkova, V., Peters, K. and Kirkpatrick, C. J. (2002) In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc. Res. 64, 384-397 (Pubitemid 35370740)
25. Olszanecki, R., Gebska, A. and Korbut, R. (2006) Production of prostacyclin and prostaglandin E2 in resting and IL-1β-stimulated A549, HUVEC and hybrid EA.HY 926 cells. J. Physiol. Pharmacol. 57, 649-660 (Pubitemid 46096111)
26. Heintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A. et al. (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39, 311-318 (Pubitemid 46328487)
27. Zabel, U., Schreck, R. and Baeuerle, P. A. (1991) DNA binding of purified transcription factor NF-κB. Affinity, specificity, Zn2+ dependence, and differential half-site recognition. J. Biol. Chem. 266, 252-260 (Pubitemid 21906116)
28. Calvanese, V., Fernandez, A. F., Urdinguio, R. G., Suarez-Alvarez, B., Mangas, C., Perez-Garcia, V., Bueno, C., Montes, R., Ramos-Mejia, V., Martinez-Camblor, P. et al. (2012) A promoter DNA demethylation landscape of human hematopoietic differentiation. Nucleic Acids Res. 40, 116-131
29. Edwards, H., Xie, C., LaFiura, K. M., Dombkowski, A. A., Buck, S. A., Boerner, J. L., Taub, J. W., Matherly, L. H. and Ge, Y. (2009) RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia. Blood 114, 2744-2752
30. Heintzman, N. D., Hon, G. C., Hawkins, R. D., Kheradpour, P., Stark, A., Harp, L. F., Ye, Z., Lee, L. K., Stuart, R. K., Ching, C. W. et al. (2009) Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108-112
31. Randis, T. M., Diacovo, N., Calafat, J. and Diacovo, T. G. (2008) Shedding light on class I phosphoinositide 3-kinase activity in endothelium. Blood 111, 4827-4828
32. Bartok, B., Boyle, D. L., Liu, Y., Ren, P., Ball, S. T., Bugbee, W. D., Rommel, C. and Firestein, G. S. (2012) PI3 kinase δ: a key regulator of synoviocyte function in rheumatoid arthritis. Am. J. Pathol., doi:10.1016/j.ajpath.2012.01.030
33. Hao, S. and Baltimore, D. (2009) The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat. Immunol. 10, 281-288
34. Chaussade, C., Rewcastle, G. W., Kendall, J. D., Denny, W. A., Cho, K., Gronning, L. M., Chong, M. L., Anagnostou, S. H., Jackson, S. P., Daniele, N. and Shepherd, P. R. (2007) Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. Biochem. J. 404, 449-458 (Pubitemid 46953919)
35. Low, P. C., Misaki, R., Schroder, K., Stanley, A. C., Sweet, M. J., Teasdale, R. D., Vanhaesebroeck, B., Meunier, F. A., Taguchi, T. and Stow, J. L. (2010) Phosphoinositide 3-kinase delta regulates membrane fission of Golgi carriers for selective cytokine secretion. J. Cell Biol. 190, 1053-1065
36. Fransson, S., Uv, A., Eriksson, H., Andersson, M. K., Wettergren, Y., Bergo, M. and Ejeskar, K. (2011) p37δ is a new isoform of PI3K p110δ that increases cell proliferation and is overexpressed in tumors. Oncogene, doi:10.1038/onc.2011.492
37. Poulikakos, P. I., Persaud, Y., Janakiraman, M., Kong, X., Ng, C., Moriceau, G., Shi, H., Atefi, M., Titz, B., Gabay, M. T. et al. (2011) RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature 480, 387-390